March 2, 2020 / 12:49 PM / a month ago

BRIEF-Akrevia Therapeutics Rebrands As Xilio Therapeutics And Announces $100.5 Mln Series B Financing

March 2 (Reuters) -

* AKREVIA THERAPEUTICS REBRANDS AS XILIO THERAPEUTICS AND ANNOUNCES $100.5 MILLION SERIES B FINANCING

* XILIO THERAPEUTICS - FINANCING LED BY TAKEDA VENTURES INCLUDES NEW INVESTORS SV HEALTH INVESTORS, MRL VENTURES FUND AND RIVERVEST VENTURE PARTNERS

* XILIO - PUNWANI, MIKE ROSS OF SV HEALTH INVESTORS, PETER DUDEK OF MRL VENTURES FUND, NANCY HONG OF RIVERVEST VENTURE PARTNERS JOINED BOARD Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below